| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000022322 |
| Receipt No. | R000025720 |
| Official scientific title of the study | Usefulness of Image enhanced endoscopy(IEE) for ACF observation |
| Date of disclosure of the study information | 2016/05/16 |
| Last modified on | 2016/05/17 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Usefulness of Image enhanced endoscopy(IEE) for ACF observation | |
| Title of the study (Brief title) | Usefulness of Image enhanced endoscopy(IEE) for ACF observation | |
| Region |
|
|
| Condition | ||
| Condition | A person having colorectal tumor | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the clinical utility of IEE, NBI and BLI, for detection of rectal ACF. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Detection rate of rectal ACF |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | colonoscopy | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | A person having colorectal tumor (adenoma or carcinoma) history | |||
| Key exclusion criteria | 1) A person who underwent surgical resection of rectum
2) Those who are taking anti-thrombotic agents such as, Aspirin, Ticlopidine, Hydrochloride, Warfarin potassium, Dipyridamole. 3) A person of inflammatory bowel disease |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Tetsuji Takayama |
| Organization | Tokushima University Graduate School, The Institute of Biomedical Sciences |
| Division name | Department of Gastroenterology and Oncology |
| Address | 3-18-15, Kuramoto-cho, Tokushima city |
| TEL | 088-633-7122 |
| takayama@tokushima-u.ac.jp | |
| Public contact | |
| Name of contact person | Kaizo kagemoto |
| Organization | Tokushima University Graduate School, The Institute of Biomedical Sciences |
| Division name | Department of Gastroenterology and Oncology |
| Address | 3-18-15, Kuramoto-cho, Tokushima city |
| TEL | 088-633-7122 |
| Homepage URL | |
| kage1733@yahoo.co.jp | |
| Sponsor | |
| Institute | Tokushima University Hospital, Department of Gastroenterology and Oncology |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Tokushima University Hospital, Department of Gastroenterology and Oncology |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025720 |